OGN vs PTRN · P/E 3.4, rev $6.40B vs rev $2.50B
Organon & Co (OGN) versus Pattern Group Inc. Series A Common Stock (PTRN) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Pattern Group Inc. Series A Common Stock (PTRN) is a software - application company listed on NASDAQ.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported PTRN revenue for 2025-12-31 was $2.50B. Net income was $16.2M. Revenue was up 39.3% from 2024-12-31 to 2025-12-31. PTRN currently screens at market cap $3.68B.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. PTRN currently screens at market cap $3.68B.
Not investment advice. Open the OGN and PTRN stock pages for the full models.
Not investment advice.